Sector: Consumer Non-Cyclicals | Industry: Personal Products |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 351 Phelps Dr IRVING TX 75038-6507 |
Tel: | N/A |
Website: | https://www.kimberly-clark.com/en-us |
IR: | See website |
Key People | ||
Michael D. Hsu Chairman of the Board, Chief Executive Officer | Tamera Fenske Senior Vice President, Chief Supply Chain Officer | Nelson Urdaneta Chief Financial Officer, Senior Vice President |
Ehab Abou-Oaf President of K-C Professional | Doug Stuart Cunningham President, K-C Europe, Middle East & Africa | Russell Torres Group President, K-C North America |
Gonzalo Uribe President, K-C Latin America | Tristram Otto Wilkinson President, K-C Asia Pacific | Sandra R.A. Karrmann Chief Human Resource Officer, Senior Vice President | Grant Mcgee Senior Vice President, General Counsel |
Business Overview |
Kimberly-Clark Corporation is principally engaged in the manufacturing and marketing of a range of products made from natural or synthetic fibers and materials using advanced technologies in fibers, nonwovens and absorbency. The Company has three segments. Personal Care segment offer solutions and products, such as disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear and other related products. Products in this segment are sold under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex and other brand names. Consumer Tissue segment offers facial and bathroom tissue, paper towels, napkins and related products, and are sold under the Kleenex, Scott, Cottonelle, Andrex, Viva, Scottex and other brand names. K-C Professional segment offers wipers, tissue, towels, personal protective equipment, soaps and sanitizers under the Kleenex, Scott, WypAll, Kimtech and KleenGuard brand name. |
Financial Overview |
For the three months ended 31 March 2024, Kimberly-Clark Corp revenues decreased 1% to $5.15B. Net income increased 14% to $647M. Revenues reflect Consumer Tissue segment decrease of 2% to $1.6B, K-C Professional segment decrease of 3% to $823M, Outside North America segment decrease of 5% to $2.4B. Net income reflects Personal Care segment income increase of 12% to $545M, Consumer Tissue segment income increase of 21% to $290M. |
Employees: | 41,000 as of Dec 31, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $53,563M as of Mar 31, 2024 |
Annual revenue (TTM): | $20,385M as of Mar 31, 2024 |
EBITDA (TTM): | $3,819M as of Mar 31, 2024 |
Net annual income (TTM): | $1,845M as of Mar 31, 2024 |
Free cash flow (TTM): | $1,013M as of Mar 31, 2024 |
Net Debt Last Fiscal Year: | $7,143M as of Mar 31, 2024 |
Shares outstanding: | 336,800,000 as of Mar 31, 2024 |
Index Membership: | S&P 500 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |